FD-OCT can detect retinal GCC atrophy

Article

In a recent study, FD-OCT demonstrated a high diagnostic ability to detect reductions in both ganglion cell complex (GCC) and retinal nerve fibre layer (RNFL) thickness in different stages of glaucoma.

In a recent study, FD-OCT demonstrated a high diagnostic ability to detect reductions in both ganglion cell complex (GCC) and retinal nerve fibre layer (RNFL) thickness in different stages of glaucoma.

Dr Mehmet Sahin Sevim and colleagues (Department of Ophthalmology, Haydarpasa Numune Research and Education Hospital, Istanbul, Turkey) included a total of 113 patients diagnosed with glaucoma and 30 healthy subjects in the study. The glaucoma patients were classified into various stages of glaucoma according to the Glaucoma Staging System 2. The retinal GCC and peripapillary RNFL were measured using FD-OCT (RTVue-100) in all patients and comparisons were made from patients in different stages of the disease.

The team found that the measurements of both GCC and RNFL thickness were statistically significantly lower when compared with the measurements taken from the healthy subjects. Additionally, the measurements were found to reduce as the stage of glaucoma progressed.

It was concluded that FD-OCT measurements of GCC and RNFL thickness demonstrated a high diagnostic ability in glaucoma detection and that it is possible to determine mean thickness values for each stage of glaucoma progression.

For more information view the abstract from the Journal of Glaucoma.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.